Nicole R. LeBoeuf MD, MPHClinical Director, Cutaneous Oncology; Director, Program in Skin Toxicities for Anticancer Therapy, Dana-Farber Cancer Institute; Assistant Professor, Dermatology, Harvard Medical School, Boston, Massachusetts
Dr. LeBoeuf received her medical degree from the University of Massachusetts Medical School in 2006. She completed her residency in Dermatology at Columbia University, where she served as Chief Resident, followed by a fellowship in Cutaneous Oncology at Brigham and Women’s/Dana-Farber Cancer Center at Harvard. Dr. LeBoeuf earned a Masters in Public Health from the Harvard TH Chan School of Public Health in 2015. She established and directs the Program in Skin Toxicities from Anticancer Therapies at the Dana-Farber/Brigham and Women’s Cancer Center. She is the Clinical Director for the Center for Cutaneous Oncology, where leads clinical trials in cutaneous lymphoma and rare skin malignancies as well as interventional studies for the prevention or management of side effects from cancer treatment. Her research focuses on understanding the immunologic mechanisms of side effects from cancer therapeutics and implementing therapies or other interventions to mitigate them.